Pfizer expects 2021, 2022 COVID-19 vaccine sales to total at least $65 billion

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. SPCX
2. CRNX
3. USO
4. VRTX
5. NVDA
6. WMT
7. SPY
8. RXST
9. RIVN
10. LMT

Go back to Pfizer expects 2021, 2022 COVID-19 vaccine sales to total at least $65 billion

Pfizer (PFE) Stock Rallies on Beat-and-Raise, Analysts Divided on How Shares Will React

November 2, 2021 8:44 AM EDT

Shares of Pfizer (NYSE: PFE) are trading over 3% higher in pre-open Tuesday after the company reported better-than-expected Q3 results and raised its FY guidance.

Pfizer reported EPS of $1.37 to easily beat the analyst estimate of $1.08. Revenue for the quarter came in at $24.1 billion versus the consensus estimate of $22.68 billion.

Dr. Albert Bourla, Chairman and Chief Executive Officer, stated: More than 75% of the revenues we have recorded up through third-quarter 2021 for Comirnaty(1) have come from... More